0001179110-20-000889.txt : 20200130 0001179110-20-000889.hdr.sgml : 20200130 20200130172349 ACCESSION NUMBER: 0001179110-20-000889 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200128 FILED AS OF DATE: 20200130 DATE AS OF CHANGE: 20200130 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: YOOR BRIAN B CENTRAL INDEX KEY: 0001643528 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-02189 FILM NUMBER: 20562383 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD STREET 2: AP6A-2, D-032L CITY: ABBOTT PARK STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ABBOTT LABORATORIES CENTRAL INDEX KEY: 0000001800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 360698440 STATE OF INCORPORATION: IL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 BUSINESS PHONE: 2246676100 MAIL ADDRESS: STREET 1: 100 ABBOTT PARK ROAD CITY: ABBOTT PARK STATE: IL ZIP: 60064-3500 4 1 edgar.xml FORM 4 - X0306 4 2020-01-28 0 0000001800 ABBOTT LABORATORIES ABT 0001643528 YOOR BRIAN B 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-6400 0 1 0 0 Executive Vice President & CFO Common shares without par value 2020-01-28 4 M 0 41229 47 A 155610 D Common shares without par value 2020-01-28 4 M 0 81709 48.90 A 237319 D Common shares without par value 2020-01-28 4 M 0 213470 38.40 A 450789 D Common shares without par value 2020-01-28 4 M 0 91121 44.40 A 541910 D Common shares without par value 2020-01-28 4 M 0 82321 59.94 A 624231 D Common shares without par value 2020-01-28 4 S 0 509850 89.7268 D 114381 D Common shares without par value 2239 I Profit Sharing Trust Option (right to buy) 47.00 2020-01-28 4 M 0 41229 0 D 2018-02-20 2025-02-19 Common shares 41229 0 D Option (right to buy) 48.90 2020-01-28 4 M 0 81709 0 D 2018-06-01 2025-05-31 Common shares 81709 0 D Option (right to buy) 38.40 2020-01-28 4 M 0 213470 0 D 2019-02-19 2026-02-18 Common shares 213470 0 D Option (right to buy) 44.40 2020-01-28 4 M 0 91121 0 D 2019-02-17 2027-02-16 Common shares 91121 45561 D Option (right to buy) 59.94 2020-01-28 4 M 0 82321 0 D 2019-02-16 2028-02-15 Common shares 82321 164642 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.57 to $89.87, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Balance in the Abbott Laboratories Stock Retirement Trust as of January 28, 2020. Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c). Jessica H. Paik, by power of attorney for Brian B. Yoor 2020-01-30